On July 9 at 1:00 PM (ET), the Green Committee will host a members-only presentation from the Environmental Protection Agency (EPA) on ecolabels and sustainable procurement. Guest speakers will be Jenna Larkin, the Acting Section Lead for the EPA's Environmentally Preferable Purchasing (EPP) Program, and Jonathan Rifkin, a Specialist and sustainable acquisition expert on the EPP team.

Taking a page out of playbook used to establish the framework that excludes products of certain Chinese telecommunications companies from the federal market (e.g., the “Huawei ban”), the BIOSECURE Act would prohibit the federal government from purchasing biotechnology equipment or services from certain “companies of concern.”  The Act does not stop there.  It would also

On July 11 at 10 AM, Thomas O’Linn, Senior Procurement Policy Analyst, Acquisition Policy Division of the Office of Government-Wide Policy at the General Services Administration, will be speaking at a meeting hosted by the Coalition's Furniture and Furnishings Committee to provide an update on the Eligibility Process for using GSA sources of supply (e.g.,

During the webinar, Stephen and Greg will discuss the critical distinctions between Average Manufacturer Price (AMP) and Weighted Average Manufacturer Price (WAMP) and their implications for both brand and generic drugs. Additionally, they will highlight and discuss a top issue impacting each program, providing you with the insights needed to stay compliant in this evolving landscape.

On July 16 at 2:00 PM (ET), the GWAC/MAC Committee is hosting a members-only meeting with Casey Kelley, Client Executive, AAS Army/Air Force, GSA. During the meeting, he will brief attendees on the latest updates and initiatives from GSA’s Assisted Acquisition Services (AAS), including AAS outlook and the status of its realignment efforts.

Join us on July 18 for an in-depth webinar focused on the Department of Veterans Affairs’ Federal Supply Schedule (FSS) Program. This session will explore five key aspects of an FSS contract that are recognized as essential by legal, pricing, compliance, finance, and contracts professionals.

As public law season rapidly approaches, it is crucial to stay informed and prepared, especially for drugs marketed under New Drug Applications (NDAs) and Biologics License Applications (BLAs). Join us on July 25 for a timely and informative webinar as Stephen Ruscus, Partner at BakerHostetler, and Greg Madden, Managing Member at Orlaithe Consulting, will guide you through the essential steps to navigate public law season.

The following CMMC webinar is open to Coalition and AMSUS-SM members.